ESR1 and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC) constitutes an operational term describing a heterogenous group of tumors that are unified only by their shared lack of expression of estrogen receptor (ER) and progesterone receptor (PR), and lack of HER2 overexpression and/or HER2 gene amplification.